A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10500058

Download in:

View as

General Info

PMID
10500058